CN102020575A - Synthesis method of L-carnitine - Google Patents

Synthesis method of L-carnitine Download PDF

Info

Publication number
CN102020575A
CN102020575A CN 201010580516 CN201010580516A CN102020575A CN 102020575 A CN102020575 A CN 102020575A CN 201010580516 CN201010580516 CN 201010580516 CN 201010580516 A CN201010580516 A CN 201010580516A CN 102020575 A CN102020575 A CN 102020575A
Authority
CN
China
Prior art keywords
carnitine
reaction
trimethylamine
cyano
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 201010580516
Other languages
Chinese (zh)
Inventor
陈志卫
苏为科
毕建豪
张春雷
陈炯明
徐灿闯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANGYU SUNFIT CHEMICAL CO Ltd
Zhejiang University of Technology ZJUT
Original Assignee
SHANGYU SUNFIT CHEMICAL CO Ltd
Zhejiang University of Technology ZJUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANGYU SUNFIT CHEMICAL CO Ltd, Zhejiang University of Technology ZJUT filed Critical SHANGYU SUNFIT CHEMICAL CO Ltd
Priority to CN 201010580516 priority Critical patent/CN102020575A/en
Publication of CN102020575A publication Critical patent/CN102020575A/en
Pending legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a synthesis method of L-carnitine with a structure shown in a formula (1), which adopts L-(-)-3-cyan-2-hydroxyl propyl trimethylamine halide as a raw material and is prepared by hydrolysis and ion exchange; the hydrolysis is carried out in the following steps: in alkaline solution, hydrogen peroxide is used for hydrolyzing the L-(-)-3-cyan-2-hydroxyl propyl trimethylamine halide, and after full reaction, the hydrolysis reaction liquid is obtained. In the technique disclosed in the invention, the reaction condition is mild, the reaction time is short, the reaction yield is high, three wastes are less, and the implementation value and social and economic benefits are larger.

Description

A kind of synthetic method of L-carnitine
(1) technical field
The present invention relates to a kind of synthetic method of L-carnitine.
(2) background technology
L-carnitine claims vitamins B again T, chemistry (3R)-(-) by name-3-hydroxyl-4-(trimethylamine groups) butyric acid has physiologically active widely.International nutrition academic conference in 1985 is classified L-carnitine as under the specified conditions essential nutritive substance.L-carnitine was in health care in recent years, and fields such as fat-reducing are widely used, and at home and abroad supply falls short of demand for its product, has very high practical value.
Before the present invention makes, the more employing of the original synthetic method of the enterprise of domestic production L-carnitine be 1988 Japanese Patent (JP63185947) report be starting raw material with (S)-(+)-epoxy chloropropane, become the quaternary ammonium salt reaction to make 3-chloro-2-hydroxypropyl Trimethylamine 99 halogenide with Trimethylamine 99, be 3-cyano group-2-hydroxypropyl Trimethylamine 99 halogenide through cyaniding again, last hydrolysis and ion-exchange obtain L-carnitine.Its intermediate nitrile compound (L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) halogenide) method for hydrolysis adopts the concentrated hydrochloric acid hydrolysis method more, and shortcoming is than higher to equipment requirements.Zeo-karb is often adopted in ion-exchange, and with a large amount of ammoniacal liquor wash-outs, ammonia nitrogen in waste water value height brings very big environmental protection pressure, and therefore, the synthetic method of developing an environmental friendliness and being easy to the L-carnitine of suitability for industrialized production has great importance.
(3) summary of the invention
It is simple to the purpose of this invention is to provide a kind of technology, and production safety is reliable, reaction yield is high, the three wastes are little, easily realize the L-carnitine chemical synthesis process of suitability for industrialized production.
The technical solution used in the present invention is as follows:
A kind of structure is suc as formula the synthetic method of the L-carnitine shown in (I), be to be raw material with the L-(-) shown in the formula (II)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) halogenide, make through hydrolysis and ion-exchange, it is characterized in that described hydrolysis adopts following method: in alkaline aqueous solution, with hydrogen peroxide hydrolysis L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) halogenide, fully obtain hydrolysis reaction liquid after the reaction.
The present invention recommends described hydrolysis reaction step as follows: in reaction vessel, add L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) halogenide, aqueous hydrogen peroxide solution and basic cpd, be warmed up to 50~80 ℃ of reaction 0.5~2h, reaction obtains hydrolysis reaction liquid after finishing; Described L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) halogenide: hydrogen peroxide: the ratio of the amount of substance that feeds intake of basic cpd is 1: 4~10: 2~6.
The present invention recommends described ion-exchange to adopt following steps: after hydrolysis reaction finishes, with the hydrolysis reaction liquid cooling but, add S-WAT and do not generate to there being bubble, reaction solution concentrates, and regulating pH is 5~7, cross Amberlite IRA-400 anionite-exchange resin, use the distilled water wash-out, collect the elutriant that contains product, concentrate, recrystallization is drying to obtain L-carnitine.
Reaction formula is as follows:
Figure BDA0000036967280000031
Further, described L-(-)-halid negatively charged ion X of 3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) is preferably chlorine, bromine or iodine.
Further, the mass concentration of described aqueous hydrogen peroxide solution is 10~50%, and preferred mass concentration is 20~45%.
Further, described basic cpd is preferably salt of wormwood, yellow soda ash, sodium hydroxide or potassium hydroxide, more preferably sodium hydroxide or potassium hydroxide.
Further, in ion exchange reaction, the solvent that described recrystallization uses is selected from following a kind of or any two kinds mixed solution: ethanol, Virahol, acetone.
Comparatively concrete, recommend the synthetic method of L-carnitine of the present invention to carry out according to following steps: according to L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) halogenide: hydrogen peroxide: the ratio of the amount of substance of basic cpd is 1: 4~10: 2~6 to add L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) halogenide, mass concentration is 10~50% aqueous hydrogen peroxide solution and basic cpd, slowly be warmed up to 50~80 ℃ of reaction 0.5~2h, after reaction finishes, cooling, adding S-WAT does not generate to there being bubble, reaction solution concentrates, regulating pH is 5~7, cross Amberlite IRA-400 anionite-exchange resin, use the distilled water wash-out, collection contains the elutriant of product, concentrate, recrystallization is drying to obtain L-carnitine.
The present invention compared with prior art, its beneficial effect is embodied in:
The present invention obtains L-carnitine with hydrogen peroxide hydrolysis L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) halogenide under alkaline system, and hydrogen peroxide decomposition is water and oxygen in the reaction process, and is nontoxic, environmental protection.Technological reaction mild condition of the present invention, the reaction times is short, the reaction yield height, the three wastes are little, have bigger implementary value and economic results in society.
(4) embodiment:
Below with specific embodiment technical scheme of the present invention is described, but protection scope of the present invention is not limited thereto:
Embodiment 1
Feed intake amount of substance than L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) muriate: hydrogen peroxide: basic cpd is 1: 10: 2.
Thermometer is being housed, in reflux condensing tube and the churned mechanically 250mL there-necked flask, add L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) muriate 17.8g (100mmol), slowly add 30% hydrogen peroxide 120g (1000mmol) and sodium hydroxide 8g (200mmol), be warming up to 70 ℃ of reaction 1.5h, after reaction finishes, cooling, adding S-WAT does not generate to there being bubble, reaction solution concentrates, with about acid for adjusting pH=5, cross Amberlite IRA-400 resin anion(R.A) exchange column, use the distilled water wash-out, collect the elutriant that contains product, concentrate, use ethanol-acetone (volume ratio 2: 1) recrystallization to obtain L-carnitine 12.1g again, product yield 75.1%, 196~197 ℃ of mp, [α] D 20-32 ° (c 10, H 2O).
Embodiment 2
Feed intake amount of substance than L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) muriate: hydrogen peroxide: basic cpd is 1: 10: 4.
Thermometer is being housed, in reflux condensing tube and the churned mechanically 250mL there-necked flask, add L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) muriate 17.8g (100mmol), slowly add 30% hydrogen peroxide 120g (1000mmol) and sodium hydroxide 16g (400mmol), be warming up to 70 ℃ of reaction 1.5h, after reaction finishes, cooling, adding S-WAT does not generate to there being bubble, reaction solution concentrates, with about acid for adjusting pH=5, cross Amberlite IRA-400 resin anion(R.A) exchange column, use the distilled water wash-out, collect the elutriant that contains product, concentrate, use ethanol-acetone (volume ratio 2: 1) recrystallization to obtain L-carnitine 12.8g again, product yield 79.5%, 196~197 ℃ of mp, [α] D 20-31.7 ° (c 10, H 2O).
Embodiment 3
Feed intake amount of substance than L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) muriate: hydrogen peroxide: basic cpd is 1: 10: 6.
Thermometer is being housed, in reflux condensing tube and the churned mechanically 250mL there-necked flask, add L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) muriate 17.8g (100mmol), slowly add 40% hydrogen peroxide 90g (1000mmol) and potassium hydroxide 33.6g (600mmol), be warming up to 65 ℃ of reaction 1.0h, after reaction finishes, cooling, adding S-WAT does not generate to there being bubble, reaction solution concentrates, with about acid for adjusting pH=7, cross Amberlite IRA-400 resin anion(R.A) exchange column, use the distilled water wash-out, collect the elutriant that contains product, concentrate, use Virahol-acetone (volume ratio 2: 1) recrystallization to obtain L-carnitine 13.9g again, product yield 86.3%, 196~198 ℃ of mp, [α] D 20-31.5 ° (c 10, H 2O).
Embodiment 4
Feed intake amount of substance than L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) muriate: hydrogen peroxide: basic cpd is 1: 8: 4.
Thermometer is being housed, in reflux condensing tube and the churned mechanically 250mL there-necked flask, add L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) muriate 17.8g (100mmol), slowly add 40% hydrogen peroxide 72g (800mmol) and potassium hydroxide 22.4g (400mmol), be warming up to 65 ℃ of reaction 2.0h, after reaction finishes, cooling, adding S-WAT does not generate to there being bubble, reaction solution concentrates, with about acid for adjusting pH=7, cross Amberlite IRA-400 resin anion(R.A) exchange column, use the distilled water wash-out, collect the elutriant that contains product, concentrate, use Virahol-acetone (volume ratio 2: 1) recrystallization to obtain L-carnitine 11.9g again, product yield 73.9%, 197~198 ℃ of mp, [α] D 20-31.2 ° (c 10, H 2O).
Embodiment 5
Feed intake amount of substance than L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) muriate: hydrogen peroxide: basic cpd is 1: 8: 6.
Thermometer is being housed, in reflux condensing tube and the churned mechanically 250mL there-necked flask, add L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) muriate 17.8g (100mmol), slowly add 45% hydrogen peroxide 64g (800mmol) and sodium hydroxide 24g (600mmol), be warming up to 65 ℃ of reaction 1.5h, after reaction finishes, cooling, adding S-WAT does not generate to there being bubble, reaction solution concentrates, with about acid for adjusting pH=5, cross Amberlite IRA-400 resin anion(R.A) exchange column, use the distilled water wash-out, collect the elutriant that contains product, concentrate, use Virahol-acetone (volume ratio 2: 1) recrystallization to obtain L-carnitine 12.4g again, product yield 77%, 197~198 ℃ of mp, [α] D 20-31.0 ° (c 10, H 2O).
Embodiment 6
Feed intake amount of substance than L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) muriate: hydrogen peroxide: basic cpd is 1: 8: 6.
Thermometer is being housed, in reflux condensing tube and the churned mechanically 250mL there-necked flask, add L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) muriate 17.8g (100mmol), slowly add 45% hydrogen peroxide 64g (800mmol) and sodium hydroxide 24g (600mmol), be warming up to 50 ℃ of reaction 2h, after reaction finishes, cooling, adding S-WAT does not generate to there being bubble, reaction solution concentrates, with about acid for adjusting pH=5, cross Amberlite IRA-400 resin anion(R.A) exchange column, use the distilled water wash-out, collect the elutriant that contains product, concentrate, use Virahol-acetone (volume ratio 2: 1) recrystallization to obtain L-carnitine 12.2g again, product yield 75.7%, 196~197 ℃ of mp, [α] D 20-31.4 ° (c 10, H 2O).
Embodiment 7
Feed intake amount of substance than L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) bromide: hydrogen peroxide: basic cpd is 1: 4: 2.
Thermometer is being housed, in reflux condensing tube and the churned mechanically 250mL there-necked flask, add L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) bromide 22.3g (100mmol), slowly add 30% hydrogen peroxide 48.0g (400mmol) and sodium hydroxide 8g (200mmol), be warming up to 80 ℃ of reaction 2h, after reaction finishes, cooling, adding S-WAT does not generate to there being bubble, reaction solution concentrates, with about acid for adjusting pH=7, cross Amberlite IRA-400 resin anion(R.A) exchange column, use the distilled water wash-out, collect the elutriant that contains product, concentrate, use Virahol-acetone (volume ratio 2: 1) recrystallization to obtain L-carnitine 11.5g again, product yield 71.4%, 196~198 ℃ of mp, [α] D 20-31.1 ° (c 10, H 2O).
Embodiment 8
Feed intake amount of substance than L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) iodide: hydrogen peroxide: basic cpd is 1: 4: 3.5.
Thermometer is being housed, in reflux condensing tube and the churned mechanically 250mL there-necked flask, add L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) iodide 26.9g (100mmol), slowly add 45% hydrogen peroxide 32g (400mmol) and sodium hydroxide 14g (350mmol), be warming up to 80 ℃ of reaction 1.5h, after reaction finishes, after reaction finishes, cooling, adding S-WAT does not generate to there being bubble, reaction solution concentrates, with about acid for adjusting pH=7, cross Amberlite IRA-400 resin anion(R.A) exchange column, use the distilled water wash-out, collection contains the elutriant of product, concentrate, use Virahol-acetone (volume ratio 2: 1) recrystallization to obtain L-carnitine 11.7g, product yield 72.6% again, 197~198 ℃ of mp, [α] D 20-31.8 ° (c 10, H 2O).

Claims (8)

1. a structure is suc as formula the synthetic method of the L-carnitine shown in (I), be to be raw material with the L-(-) shown in the formula (II)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) halogenide, make through hydrolysis and ion-exchange, it is characterized in that described hydrolysis adopts following method: in alkaline aqueous solution, with hydrogen peroxide hydrolysis L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) halogenide, fully obtain hydrolysis reaction liquid after the reaction;
Figure FDA0000036967270000011
2. the synthetic method of L-carnitine as claimed in claim 1, it is characterized in that described hydrolysis reaction step is as follows: in reaction vessel, add L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) halogenide, aqueous hydrogen peroxide solution and basic cpd, be warmed up to 50~80 ℃ of reaction 0.5~2h, reaction obtains hydrolysis reaction liquid after finishing; Described L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) halogenide: hydrogen peroxide: the ratio of the amount of substance that feeds intake of basic cpd is 1: 4~10: 2~6.
3. the synthetic method of L-carnitine as claimed in claim 1, it is characterized in that described ion-exchange employing following steps: after hydrolysis reaction finishes, with the hydrolysis reaction liquid cooling but, add S-WAT and generate to there being bubble, reaction solution concentrates, regulating pH is 5~7, crosses Amberlite IRA-400 anionite-exchange resin, uses the distilled water wash-out, collection contains the elutriant of product, concentrate, recrystallization is drying to obtain L-carnitine.
4. as the synthetic method of the described L-carnitine of one of claim 1~3, it is characterized in that described L-(-)-halid negatively charged ion X of 3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) is chlorine, bromine or iodine.
5. the synthetic method of L-carnitine as claimed in claim 2 is characterized in that described basic cpd is salt of wormwood, yellow soda ash, sodium hydroxide or potassium hydroxide.
6. the synthetic method of L-carnitine as claimed in claim 2, the mass concentration that it is characterized in that described aqueous hydrogen peroxide solution is 10~50%.
7. the synthetic method of L-carnitine as claimed in claim 3 is characterized in that the solvent that described recrystallization uses is following a kind of or any two kinds mixed solution: ethanol, Virahol, acetone.
8. the synthetic method of L-carnitine as claimed in claim 1, it is characterized in that described synthetic method carries out according to following steps: according to L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) halogenide: hydrogen peroxide: the ratio of the amount of substance of basic cpd is 1: 4~10: 2~6 to add L-(-)-3-cyano-2-hydroxy-propyl group TMA (TriMethylAmine) halogenide, mass concentration is 10~50% aqueous hydrogen peroxide solution and basic cpd, slowly be warmed up to 50~80 ℃ of reaction 0.5~2h, after reaction finishes, cooling, adding S-WAT does not generate to there being bubble, reaction solution concentrates, regulating pH is 5~7, cross Amberlite IRA-400 anionite-exchange resin, use the distilled water wash-out, collection contains the elutriant of product, concentrate, recrystallization is drying to obtain L-carnitine.
CN 201010580516 2010-12-09 2010-12-09 Synthesis method of L-carnitine Pending CN102020575A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201010580516 CN102020575A (en) 2010-12-09 2010-12-09 Synthesis method of L-carnitine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201010580516 CN102020575A (en) 2010-12-09 2010-12-09 Synthesis method of L-carnitine

Publications (1)

Publication Number Publication Date
CN102020575A true CN102020575A (en) 2011-04-20

Family

ID=43862396

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201010580516 Pending CN102020575A (en) 2010-12-09 2010-12-09 Synthesis method of L-carnitine

Country Status (1)

Country Link
CN (1) CN102020575A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102351722A (en) * 2011-08-10 2012-02-15 江西新先锋医药有限公司 L-carnitine compound and composite thereof
CN105481709A (en) * 2015-08-19 2016-04-13 广西壮族自治区化工研究院 Method for purifying and desalting crude product of L-carnitine
CN111233686A (en) * 2019-12-24 2020-06-05 常州寅盛药业有限公司 Method for recrystallizing levocarnitine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999062864A1 (en) * 1998-05-29 1999-12-09 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Chemical process for the stereoselective synthesis of r-(-)-carnitine
JP2008133198A (en) * 2006-11-27 2008-06-12 Mitsubishi Rayon Co Ltd Method for producing l-carnitine
CN101823974A (en) * 2010-05-20 2010-09-08 北京科技大学 Preparation method by adopting (R)-(-)-glycerinchlorohydrin as chirality starting material to synthetize L-carnitine

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999062864A1 (en) * 1998-05-29 1999-12-09 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Chemical process for the stereoselective synthesis of r-(-)-carnitine
JP2008133198A (en) * 2006-11-27 2008-06-12 Mitsubishi Rayon Co Ltd Method for producing l-carnitine
CN101823974A (en) * 2010-05-20 2010-09-08 北京科技大学 Preparation method by adopting (R)-(-)-glycerinchlorohydrin as chirality starting material to synthetize L-carnitine

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102351722A (en) * 2011-08-10 2012-02-15 江西新先锋医药有限公司 L-carnitine compound and composite thereof
CN102351722B (en) * 2011-08-10 2012-08-29 江西新先锋医药有限公司 L-carnitine compound and composite thereof
CN105481709A (en) * 2015-08-19 2016-04-13 广西壮族自治区化工研究院 Method for purifying and desalting crude product of L-carnitine
CN111233686A (en) * 2019-12-24 2020-06-05 常州寅盛药业有限公司 Method for recrystallizing levocarnitine

Similar Documents

Publication Publication Date Title
EP2754652A1 (en) Taurine preparation method
CN103664665A (en) Solid sodium sarcosine preparation method
CN103232355B (en) Environmentally-friendly clean production method of iminodiacetic acid
CN104557597B (en) A kind of clean preparation method of 3 (N, N bis- replaces) aminoacenaphthene amine compounds
CN105063120B (en) A kind of preparation method of Levetiracetam
CN102020575A (en) Synthesis method of L-carnitine
CN107619373A (en) A kind of method for continuously synthesizing of high-purity paranitroaniline
CN114524738A (en) Glycine preparation method for reducing iminodiacetic acid content
CN107880072B (en) A kind of preparation method of glufosinate-ammonium
CN101838212B (en) Method for synthesizing L-carnitine by using (R)-(-)-3-chlorine-1,2-propylene glycol as chiral initiative raw material
WO2013159742A1 (en) Device and method for preparing dl-methionine
CN103524411B (en) Synthetic method of 5-cholro-8-quinoline oxyacetic acid
CN105837432A (en) Novel preparation method of 3,5-dichlorobenzoyl chloride
CN106748839B (en) A kind of clean preparation method of glycine and iminodiacetic acid coproduction
CN102924244A (en) Production technique of high-quality trimethyl orthoacetate
CN109503418A (en) A kind of preparation process of methyl hydrazine
CN102688610B (en) Chromatographic separation method of glycine and inorganic salt
CN108017561A (en) A kind of method of refined card glutamic acid
CN105836814B (en) The method of one kind synthesis ammino palladium (II) of sulfuric acid four
CN110438524B (en) Method for preparing diethylenetriamine by electrochemical reduction of iminodiacetonitrile
CN108558686B (en) Preparation method of bupropion hydrochloride
CN101830438A (en) Method for purifying simple substance bromine from hydrobromic acid mother liquor
CN102329243B (en) Tubular reaction method of L-(-)-3-chloro-2-hydroxypropyl trimethyl ammonium chloride
CN101519360A (en) Method for preparing iminodiacetic acid
KR20030095999A (en) Improved Process for Producing Acetone Cyanohydrin

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110420